Acute Coronary Syndrome

       　急性冠脉综合征(ACS)是由于冠状动脉内粥样硬化斑块破裂或溃烂,继之出血和血栓形成,引起冠状动脉血流完全或不完全堵塞的病理生理改变而导致的综合征，临床表现为不稳定性心绞痛(UA)、非ST段抬高心肌梗死（NSTEMI）及ST段抬高心肌梗死（STEMI）。其起病急，致死率高，其防治一直是临床和基础研究的重点热点。为此，CMBI特准备了关于Acute Coronary Syndrome的特别报导，供大家参考。更多的文献，请用相关关键词通过CMBI文献查询获取。

• Redefining Risk in Acute Coronary Syndromes Using Molecular Medicine
  
• Impact of a negative prior stress test on emergency physician disposition decision in ED patients with chest pain syndromes
  
• How can we identify low-and high-risk patients among unselected patients with possible acute coronary syndrome
  
• Global Registry of Acute Coronary Events (GRACE) hospital discharge risk score accurately predicts long-term mortality post acute coronary syndrome
  
• CXCL16 Is a Marker of Inflammation, Atherosclerosis, and Acute Coronary Syndromes in Humans
  
• A quality guarantee in acute coronary syndromes
  
• Use of Heparins in Non-ST-Elevation Acute Coronary Syndromes
  
• Persistent Activation of Nuclear Factor Kappa-B Signaling Pathway in Patients With Unstable Angina and Elevated Levels of C-Reactive Protein
  
• A Comparison of Acute Coronary Syndrome Care at Academic and Nonacademic Hospitals
  
• Prevalence of Metabolic Syndrome After Acute Coronary Syndrome and Its Prognostic Significance
  
• Plaque ruptures in stable angina pectoris compared with acute coronary syndrome
  
• Course of Depressive Symptoms and Medication Adherence After Acute Coronary Syndromes
  
• Cardiac Troponin T at 96 Hours After Acute Myocardial Infarction Correlates With Infarct Size and Cardiac Function
  
• Bivalirudin for Patients with Acute Coronary Syndromes
  
• Relation Between Soluble Intercellular Adhesion Molecule-1, Statin Therapy, and Long-Term Risk of Clinical Cardiovascular Events in Patients With Previous Acute Coronary Syndrome (from PROVE IT-TIMI 22)
  
• Short-and Long-Term Risk Stratification in Acute Coronary Syndromes
  
• Adverse Impact of Bleeding on Prognosis in Patients With Acute Coronary Syndromes
  
• Acute Coronary Syndrome May Occur With In-Stent Restenosis and Is Associated With Adverse Outcomes (The PRESTO Trial)
  
• A Randomized Comparison of High Clopidogrel Loading Doses in Patients With Non–ST-Segment Elevation Acute Coronary Syndromes
  
• The Year in Non–ST-Segment Elevation Acute Coronary Syndromes
  
• Seasonality and Daily Weather Conditions in Relation to Myocardial Infarction and Sudden Cardiac Death in Olmsted County, Minnesota, 1979 to 2002
  
• Acute Clopidogrel Use and Outcomes in Patients With Non–ST-Segment Elevation Acute Coronary Syndromes Undergoing Coronary Artery Bypass Surgery
  
• Soluble CD40L Levels Are Regulated by the-3459 AG Polymorphism and Predict Myocardial Infarction and the Efficacy of Antithrombotic Treatment in Non-ST Elevation Acute Coronary Syndrome.
  
• Hopelessness and Depression in the Early Recovery Period After Hospitalization for Acute Coronary Syndrome.
  
• Effects of Early Treatment With Statins on Short-term Clinical Outcomes in Acute Coronary Syndromes
  
• Comparison of Fondaparinux and Enoxaparin in Acute Coronary Syndromes
  
• Genetic background of acute coronary syndromes
  
• Can symptom presentation predict unstable anginanon-ST-segment elevation myocardial infarction in a moderate-risk cohort
  
• Are predictors for myocardial infarction the same for women and men when evaluated prior to hospital admission
  
• A Nursing Intervention to Reduce Prehospital Delay in Acute Coronary Syndrome
  
• A cost-utility analysis of clopidogrel in patients with non-ST-segment-elevation acute coronary syndromes in the UK
  
• A comparative study of markers of inflammation for the assessment of cardiovascular risk in patients presenting to the emergency department with acute chest pain suggestive of acute coronary syndrome
  
• Pro-inflammatory-anti-inflammatory cytokine imbalance in acute coronary syndromes
  
• Comparison of Fondaparinux and Enoxaparin in Acute Coronary Syndromes
  
• Acute Coronary Syndrome
  
• Early determination of homocysteine levels in acute coronary syndromes, is it an independent prognostic factor
  
• Chronic Kidney Disease in Patients with Non–ST-Segment Elevation Acute Coronary Syndromes
  
• Antibiotic Treatment of Chlamydia pneumoniae after Acute Coronary Syndrome
  
• The Role of Risk Stratification in the Decision to Provide Upstream Versus Selective Glycoprotein IIbIIIa Inhibitors for Acute Coronary Syndromes
  
• The Effect of Valsartan, Captopril, or Both on Atherosclerotic Events After Acute Myocardial Infarction
  
• Serum Blood Urea Nitrogen as an Independent Marker of Subsequent Mortality Among Patients With Acute Coronary Syndromes and Normal to Mildly Reduced Glomerular Filtration Rates
  
• Assessment of Vulnerable Plaques Causing Acute Coronary Syndrome Using Integrated Backscatter Intravascular Ultrasound
  
• Patient-related variables predicting acute coronary syndrome following admission for chest pain of possible coronary origin
  
• Outcomes after acute coronary syndrome admission to primary versus tertiary Veterans Affairs medical centers
  
• Long-term cost-effectiveness of early and sustained clopidogrel therapy for up to 1 year in patients undergoing PCI after presenting with acute coronary syndromes without ST-segment elevation
  
• Improved outcome after acute coronary syndromes with an intensive versus standard lipid-lowering regimen
  
• Frequency and Clinical Implications of Discordant Creatine Kinase-MB and Troponin Measurements in Acute Coronary Syndromes
  
• Elevated Plaque Temperature in Non-Culprit De Novo Atheromatous Lesions of Patients With Acute Coronary Syndromes
  
• Elevated Placental Growth Factor Levels Are Associated With Adverse Outcomes at Four-Year Follow-Up in Patients With Acute Coronary Syndromes
  
• Elevated creatine kinase-MB with normal creatine kinase predicts worse outcomes in patients with acute coronary syndromes
  
• Alternative Causes for Elevated Cardiac Troponin Levels when Acute Coronary Syndromes Are Excluded
  
• Acute coronary syndrome and chronic infection in the Cork coronary care case-control study
  
• Systemic inflammatory markers in acute coronary syndrome
  
• Influence of the new definition of acute myocardial infarction on coronary care unit admission, discharge diagnosis, management and outcome in patients with non-ST elevation acute coronary
  
• Incremental diagnostic value of ultrasonographic assessment of coronary flow reserve with high-dose dipyridamole in patients with acute coronary syndrome
  
• Genetic Variations in the Tissue Factor Gene Are Associated With Clinical Outcome in Acute Coronary Syndrome and Expression Levels in Human Monocytes
  
• Direct versus conventional stent implantation in patients with acute coronary syndrome just before the era of drug-eluting stents
  
• Comparative Accuracy of Manual Versus Computerized Electrocardiographic Measurement of J-, ST-and T-Wave Deviations in Patients With Acute Coronary Syndrome
  
• Balloon-Floating Right Heart Catheter Monitoring for Acute Coronary Syndromes Complicated by Heart Failure – Discordance between Guidelines and Reality
  
• Appropriate invasive and conservative strategies for patients with non-ST elevation
  
• The Potential Relevance of the Multiple Lipid-Independent (Pleiotropic) Effects of Statins in the Management of Acute Coronary Syndromes
  
• The Influence of Race on Health Status Outcomes One Year After an Acute Coronary Syndrome
  
• Safety and effectiveness of transdermal nicotine patch in smokers admitted with acute coronary syndromes
  
• Relation between baseline risk and treatment decisions in non-ST elevation acute coronary syndromes
  
• Pregnancy-associated plasma protein-A levels in patients with acute coronary syndromes
  
• In-Hospital Initiation of Statin Therapy in Acute Coronary Syndromes
  
• Gender disparities in the diagnosis and treatment of non–ST-segment elevation acute coronary syndromes
  
• Differences in the Management and Prognosis of Women and Men Who Suffer From Acute Coronary Syndromes
  
• Circulating Secretory Phospholipase A2 Activity Predicts Recurrent Events in Patients With Severe Acute Coronary Syndromes
  
• Cigarette smoking and acute coronary syndromes
  
• Management of non-ST-elevation acute coronary syndromes
  
• Management and outcomes of lower risk patients presenting with acute coronary syndromes in a multinational observational registry.
  
• Enhanced T-Helper-1 Lymphocyte Activation Patterns in Acute Coronary Syndromes
  
• Early invasive strategy in elderly patients with non-ST elevation acute coronary syndrome
  
• Analysis of bleeding complications associated with glycoprotein IIbIIIa receptors blockade in patients with high-risk acute coronary syndromes
  
• The interleukin-6-174 GNC promoter polymorphism is associated with a higher risk of death after an acute coronary syndrome in male elderly patients
  
• Serum tryptase levels in acute coronary syndromes
  
• Relationship Between Risk Stratification by Cardiac Troponin Level and Adherence to Guidelines for Non-ST-Segment Elevation Acute Coronary Syndromes.
  
• Red wine reduces oxidative stress in patients with acute coronary syndrome
  
• Interleukin-18 Interleukin-10 ratio and in-hospital adverse events in patients with acute coronary syndrome
  
• Early Invasive versus Selectively Invasive Management for Acute Coronary Syndromes
  
• Treatment and short-term outcome in women and men with acute coronary syndromes
  
• Gender differences in the presentation and management of acute coronary syndromes
  
• Clopidogrel in non-ST segment elevation acute coronary syndromes
  
• Cardiovascular risk factors and clinical presentation in acute coronary syndromes
  
• The Site of Plaque Rupture in Native Coronary Arteries
  
• Normal angiogram in acute coronary syndromes
  
• Management and Outcomes of Elderly Women and Men With Acute Coronary Syndromes in 2000 and 2002.
  
• High frequency of endothelial vasomotor dysfunction after acute coronary syndromes in non-culprit and angiographically normal coronary arteries
  
• Treatment and outcomes of eastern Europeans with coronary syndromes in OPUS-TIMI 16
  
• Thirty day prognosis of patients with acute pulmonary oedema complicating acute coronary syndromes
  
• Routine vs Selective Invasive Strategies in Patients With Acute Coronary Syndromes
  
• Impact of combined pharmacologic treatment with clopidogrel and a statin on outcomes of patients with non-ST-segment elevation acute coronary syndromes
  
• Capability of ischemia-modified albumin to predict serious cardiac outcomes in the short term among patients with potential acute coronary syndrome
  
• Potential Impact of the HIPAA Privacy Rule on Data Collection in a Registry of Patients With Acute Coronary Syndrome.
  
• Lack of clopidogrel-CYP3A4 statin interaction in patients with acute coronary syndrome.
  
• Gender and myocardial salvage after reperfusion treatment in acute myocardial infarction
  
• Expansion of Circulating Toll-Like Receptor 4-Positive Monocytes in Patients With Acute Coronary Syndrome.
  
• High-density lipoprotein, but not low-density lipoprotein cholesterol levels influence short-term prognosis after acute coronary syndrome
  
• Geographical influences on the association between adherence to the Mediterranean diet and the prevalence of acute coronary syndromes, in Greece
  
• Depressive symptoms and treatment after acute coronary syndrome
  
• Contemporary management of acute coronary syndrome.
  
• Behavioral and Emotional Triggers of Acute Coronary Syndromes-A Systematic Review and Critique
  
• Association of Hemoglobin Levels With Clinical Outcomes in Acute Coronary Syndromes.
  
• What causes acute coronary syndromes
  
• Thrombocytopenia in Cardiovascular Patients
  
• Prehospital identification of acute coronary syndromemyocardial infarction in relation to ST elevation
  
• Management of acute coronary syndromes, a questionnaire survey of the clinical practice of cardiologists and other medical physicians belonging to west midland hospitals
  
• CD14 C(-260)T promoter polymorphism and prevalence of acute coronary syndromes
  
• Acute coronary syndromes do not promote prolonged in vivo FXII-dependent prothrombotic activity
  
• Circulating endothelial cells, von Willebrand factor, interleukin-6, and prognosis in patients with acute coronary syndromes
  
• Acute coronary syndromes do not promote prolonged in vivo FXII-dependent prothrombotic activity